Medical Device | March 17, 2022
Agilent establishes Centre for Excellence at Gujarat Technological University
The facility will enable research initiatives in analytical chemistry, biopharmaceuticals, and life sciences
The facility will enable research initiatives in analytical chemistry, biopharmaceuticals, and life sciences
The focus is to build collaborative learning and sharing ecosystem
The new solution, built on patented blockchain technology, dynamically adapts to patients' behaviour patterns to make clinical encounters more effective
Feedback and remarks of the industry and stakeholders are invited till the 25th of March 2022
The Gujarat Biotechnology policy released last month has made radical changes to position the state as a biotechnology hub. It already has a thriving ecosystem of pharma companies and varied suppliers
Investment in technology and people and a meaningful industry-academia partnership can fuel the growth of the Indian biopharma sector
Citizens will be able to create their ABHA (Ayushman Bharat Health Account) numbers, to which their digital health records can be linked
This policy will ensure multi-disciplinary collaboration, promote start-up culture and develop an innovation-led ecosystem at medical institutes across the country
Industry leaders discusses the need of innovation for the Indian drug industry at BioAsia 2022.
AIIA partners with Startup India with the aim to identify and support innovations and start-ups working in the Ayush sector
Subscribe To Our Newsletter & Stay Updated
